Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
about
Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@en
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@nl
type
label
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@en
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@nl
prefLabel
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@en
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@nl
P2093
P2860
P356
P1476
Novel composite efficacy measu ...... rrent herpes simplex labialis.
@en
P2093
Christopher M Hull
Myron J Levin
Spotswood L Spruance
Stephen K Tyring
P2860
P304
P356
10.1128/AAC.02150-13
P407
P577
2013-12-16T00:00:00Z